Hospital Universitario Hm Sanchinarro — Clinical Trial Site

446 Registered trials

178 Currently recruiting

Organisation

Hospital Universitario Hm Sanchinarro

Location

Madrid, Spain

Identifier

ORG-100041243

Address

Calle Ona 10, 28050, Spain

Departments

-
#03401: START
#1401: Oncología
#2201: Oncología médica
#2201: START Madrid-HM CIOCC Early Phase Program
#2409: Oncología
#3004:Oncology
#3032403: N/A
#3102:Oncología médica
#3301: START Madrid- Centro Integral Oncologico Clara Campal
#40615:Memory Disorders Unit
#7001:Medical Oncology
034-04: Oncology
2001: Oncología
3304: Oncologia
602 : Oncología Médica
7000: Oncología médica
7001: CIOCC Phase I Unit
803: Servicio de Oncología Médica, Sótano -1
9003: Hematología
9400:Oncología Médica
Centro Integral Oncológico Clara Campal
Centro Integral Oncológico Clara Campal (CIOCC)
Centro Integral Oncológico Clara Campal (CIOCC) Phase I Trials Unit
Centro Integral Oncologico Clara Campal CIOCC
Centro Integral Oncológico Clara Campall
Centro Integral Oncológico Clara Campall (CIOCC) Phase I trials unit
CIOCC
CIOCC Early Phase Program
CIOCC Phase I trials
CIOCC- Medical Oncology- Digestive Unit
CIOCC, Ensayos Clínicos planta S-1
Clinical Investigator Early Phase Trials Unit
Dermatology
Early phase drug development
Ensayos Clinicos
Ensayos Clínicos Fases I START
ESP020: Oncología
Head and Neck and Cancer, Gastrointestinal Cancer Unit
Hematología
Hematología y Hemoterapia
Hematologist
Hematology
Hematology and Hemotherapy
Hematology and Hemotherapy Medical Oncology
Hematology Unit
Infecciosas
Internal Medicine
MEDICAL ONCOLOGIST
Medical Oncology
Medical Oncology Department
Medical Oncology Service
Medical Oncology/phase 1 trials unit
Medicina Nuclear
N/A
Neumología
Neurology
Neurooncología
Not applicable
Nuclear Medicine
Onccology Department
Oncologfa, Ensayos Clfnicos Fases I START Madrid-CIOCC
Oncología
Oncología - START MADRID
Oncología Médica
Oncologia Meidica
Oncología Radioterápica
Oncología, Unidad de Fase I START Madrid-CIOCC
Oncology
Oncology Department
Oncology Medicine
Oncology Phase I trials unit
Oncology Phase I Unit
Oncology Service
Oncology, Clínical Trials Phase I START Madrid-CIOCC Centro Integral Oncologico Clara Campal
Oncology, Clínical Trials Phase I START Madrid-CIOCC Centro Integral Oncologico Clara Campal
Pediatrics
Phase 1 Unit, 3rd floor
Phase I Trials
Phase I trials unit
Phase I Unit
Phase I- START MADRID CIOCC Unit
Physican
Pneumology
Pneumonology
Pulmonology
Rheumatology
Servicio de Hematologia
Servicio de Hematologia y Oncohematologia
Servicio de Neurología
Servicio de Oncología
Servicio de Oncología Médica
Servicio Hematología y Hemoterapia / Oncología, Ensayos Clínicos Fases I START-Madrid-CIOCC
START
Start - Centro Integral Oncológico Clara Campal
START Early Phase Clinical Trial Program
START Madrid
START Madrid - CIOCC
START Madrid – CIOCC
START Madrid CIOCCHM Sanchinarro Hospital Phase I trials Unit
Start Madrid Sanchinarro
START Madrid-CIOCC
START Madrid-CIOCC (Unidad de Ensayos Fase 1)
START Madrid-CIOCC Phase I Unit
START Madrid-HM CIOCC
START Madrid-HM CIOCC Early Phase Program
START-Madrid-CIOCC
Thoracic Oncology
Unidad Central de Ensayos Clinicos
Unidad de Ensayos Clínicos START Madrid # CIOCC
Unidad de Ensayos Fases I
Unidad Fases I Star
Urology

Clinical trials at this site (446)

Search interface

A Study of SGN-B7H4V in Advanced Solid Tumors Ended

2023-503389-22-00 Fallopian tube cancer 1 2022-08-31
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed S… Ended

2024-513559-34-00 Small Cell Lung Cancer (SCLC) 5 2022-07-19
Study of RP2 alone and in combination with PD1 Blockade in patients with solid tumours Ended

2024-512866-32-00 Solid tumors 7 2022-07-12
Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma (CLAUDIO-01) Ended

2023-504441-31-00 gastric adenocarcinoma or adenocarcinoma of the gastroe 7 2022-06-29
A study in people with advanced cancer to test whether the amount of BI 907828 in the blood is influenced by taking an OATP inhibitor or a C… Ended

2024-514532-24-00 Solid cancer tumors 3 2022-06-23
IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma Ended

2024-511996-13-00 Previously untreated, unresectable, or metastatic melan 5 2022-05-11
Safety and preliminary efficacy trial of BNT142 in patients with CLDN6-positive advanced ovarian, lung, or testicular cancer Ended

2024-512639-58-00 Solid Tumors 7 2022-05-07
"OPAL Master Protocol Phase 1B/2 Multicohort Umbrella Study to Evaluate the Safety and Efficacy of Novel Treatments and/or Combinations of T… Ended

2023-505097-16-00 Ovarian Neoplasms 4 2022-04-04
Advanced hormone receptor-positive/HER2-negative/HER2-Enriched breast cancer Ended

2023-508828-35-01 Patients with advanced hormone receptor-positive/HER2- 5 2022-03-28
Brightline-1: A study to compare brigimadlin (BI 907828) with doxorubicin in people with a type of cancer called dedifferentiated liposarcom… Ended

2024-511361-11-00 Advanced dedifferentiated liposarcoma 10 2022-03-25
A Phase 2 Trial of SCO-101 in combination with FOLFIRI for Patients with Metastatic Colorectal Cancer (mCRC) with acquired Resistance to FOL… Ended

2024-518877-33-00 Metastatic Colorectal Cancer 4 2022-03-17
A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Clinical Activity of RO7276389 Alone and in Combination with Cobimetinib in Pa… Ended

2023-506310-43-00 BRAF-V600 Mutation-Positive Advanced Solid Tumor or BRA 1 2022-02-15
GEN1047 for Solid Tumors - First in Human (FIH) Trial Ended

2024-510722-10-00 Malignant Solid Tumors 7 2021-12-13
LAVA1207-001/LAVA1207-002 A Phase 1 and 2a open-label trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immun… Ended

2024-515821-27-00 Prostate Cancer 9 2021-11-30
Phase IB Study to Assess the Safety, Tolerability and Efficacy of PM14 in combination with Atezolizumab in Pretreated Patients with Selected… Ended

2023-509688-25-00 Advanced solid tumors 3 2021-11-23
A study to learn if bepranemab is safe and works in people with early stages of Alzheimer’s Disease Ended

2023-506170-12-00 Alzheimer’s Disease 4 2021-10-18
First-in-Human Study of RLY-4008 in Patients With ICC and Other Advanced Solid Tumors Ended

2024-512622-29-00 Cholangiocarcinoma (CCA) and Other Advanced Solid Tumor 7 2021-09-10
A study of PRS-344/S095012 (PD-L1x4-1BB bispecific antibody) in patients with solid tumors Ended

2023-510046-25-00 Soild Tumors 7 2021-09-02
Study of REGN6569 and Cemiplimab in Adult Patients with Advanced Solid Tumor Malignancies Ended

2022-500868-36-00 Squamous Cell Carcinoma of Head and Neck 1 2021-08-11
A Phase 2 Study of ALX148 in Combination with Pembrolizumab in Patients with Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) Ended

2023-508340-22-00 metastatic or unresectable, recurrent HNSCC 4 2021-08-11
A Phase 2 study of ALX148 in Combination With Pembrolizumab and Chemotherapy in Patients with Advanced Head and Neck Squamous Cell Carcinoma… Ended

2023-508342-17-00 metastatic or unresectable, recurrent HNSCC 4 2021-08-11
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of Inavolisib in Combination with Paclit… Ended

2023-506745-33-00 Locally Advanced or Metastatic Solid Tumors 3 2021-07-12
Eptinezumab as Preventive Treatment of Migraine in Adults with Migraine Ended

2023-510183-12-00 Chronic migraine 5 2021-07-05
Study of Atezolizumab plus chemotherapy plus chemo-radiotherapy and Atezolizumab maintenance therapy in non-resectable non-small cell lung c… Ended

2024-514803-33-00 Non-small cell lung cancer (NSCLC) 4 2021-06-16